Meningococcal disease
Conditions & Treatments
Choose from these
common conditions

Browse treatment centers:
Drug Reviews
Browse our A to Z list
Who should be vaccinated?

Two vaccines are available in the United States to help prevent meningococcal disease.1 2 These are called:

  • Menomune (MPSV4)
  • Menactra (MCV4).
Both of these vaccines work against four different types of meningococcal bacteria (groups A, C, Y and W-135).

Menactra is recommended for anyone between 11 and 18.1 2 It should be given as early as possible, usually when a child reaches 11 or 12.

You may also be advised to have this vaccine if you:

  • Are a high school freshman
  • Are a college freshman living in a dormitory
  • Are a military recruit
  • Have a damaged spleen (or you've had your spleen removed)
  • Have problems with your immune system
  • Are traveling to countries where there's an outbreak of meningococcal disease
  • Might have been exposed to meningitis during an outbreak.
If you're between 11 and 55, you'll usually be given Menactra, although Menomune can also be used.

Menomune is recommended for:

  • Children between 2 and 10
  • Adults over 55.
Recently, five people who took the Menactra vaccine went on to get Guillain-Barré syndrome.3 Guillain-Barré syndrome causes weakness and breathing difficulties. We don't know if the vaccine caused this problem. These cases are being investigated by the Food and Drug Administration, which checks the safety of drugs in the United States.



Sources for the information on this page:
  1. Centers for Disease Control and Prevention. Meningococcal disease. Available at http://www.cdc.gov (accessed on 2 June 2008).
  2. Centers for Disease Control and Prevention. Notice to Readers: Revised Recommendations of the Advisory Committee on Immunization Practices to Vaccinate All Persons Aged 11--18 Years with Meningococcal Conjugate Vaccine. August 2007. Available at http://www.cdc.gov/MMWR (accessed on 2 June 2008).
  3. U.S. Food and Drug Administration. FDA and CDC issue alert on Menactra meningococcal vaccine and Guillain Barre Syndrome. Available at http://www.fda.gov (accessed on 2 June 2008).
This information was last updated in Jun 08, 2008